Kestra Medical CBO Timothy Moran sells $348,310 in shares

Chief Business Officer Timothy P. Moran of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) sold shares of the company's common stock recently, according to a Securities and Exchange Commission filing. The transactions occurred on July 30, July 31, and August 3, 2026, and totaled $348,310 in sales. The shares sold were nondiscretionary and used to meet tax withholding obligations related to vested and settled restricted stock units.

Moran's ownership in Kestra Medical is currently valued at 66,345 common shares. The stock has shown a significant increase since these transactions, now trading at $28.02, up from the sale prices of $22.6054 to $23.7611 per share. Analysts and financial platforms have provided mixed opinions on the stock's valuation, with some suggesting it is overvalued relative to its intrinsic value.

Despite this, Kestra Medical reported impressive revenue growth for its fiscal fourth quarter of 2026, with a 66% increase to $28.64 million, although it missed earnings expectations. Several financial firms have revised their ratings and price targets for Kestra Medical in light of these results.